Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278406 · ClinicalTrials.gov registry record · NA
Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02278406 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT02278406, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if deep brain stimulation can change brain oxygen levels in people with Parkinson's Disease. Measurements will be taken using a non-invasive device while subjects are both on and off their medications, and while their stimulator is in the on and off setting.
Interventions
- OTHER Deep brain stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278406
The ClinicalTrials.gov registry entry for NCT02278406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deep brain stimulator is the first listed.
NCT02278406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02278406 about?
NCT02278406 is a clinical study titled "Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators". The purpose of this study is to determine if deep brain stimulation can change brain oxygen levels in people with Parkinson's Disease. Measurements will be taken using a non-invasive device while subjects are both on and off their medications, and while their stimulator is in the on and off setting.
What is the current status of trial NCT02278406?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-10. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02278406?
The interventions under investigation include: Deep brain stimulator (OTHER).
Who is sponsoring clinical trial NCT02278406?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.